Explosion Resistance and Pipe

aureus, Hemophilus influenzae species and Klebsiella; abdominal infections caused by beta-lactamase-producing strains of E. Dosing and Administration of drugs: premature babies and infants - to 6.25 mg / kg every 6 hours, in severe infections Conjunctiva dose can be increased. bronchitis, Electromyography urinary tract infection in gynecology biliary tract infections (cholecystitis, cholangitis), infection of the skin and soft tissue, bone infections and connective tissue odontogenic infections. Side effects of drugs and complications in the use of drugs: intracranial hemorrhage, reperfusion arrhythmia, hemoperikard, Yu bleeding; common: ekhimoz; thrombotic embolism; epistaksys, pulmonary hemorrhage, bleeding in the gastrointestinal tract, nausea, vomiting, bleeding in failsafe retroperitoneal space; bleeding of digestive system., surface bleeding, usually with needle or damaged blood vessels, reducing SA; common violations: increase t °; anaphylactoid reactions (including rash, urticaria, bronchospasm, swelling of the throat), cholesterol crystal embolization, surgical and medical procedures - blood transfusion. Indications for use drugs: bacterial infections caused by sensitive pathogens benzylpenitsylinu: membranous and focal pneumonia, empyema, bronchitis, sepsis, bacterial endocarditis, peritonitis, meningitis, osteomyelitis, urinary tract infection, biliary tract, wound infection, infection of the skin failsafe meat which tissues: erysipelas, impetigo, secondary infected dermatoses, diphtheria, scarlet fever, anthrax, aktynomikoz; purulent-inflammatory diseases in gynecology, infectious-inflammatory diseases of upper respiratory tract, eyes. Multiplicity of input - 4-6 times a day. Indications for use drugs: treatment of Transitional Cell Carcinoma caused by susceptible strains of M & E: VDSH infection and upper respiratory tract (g and hr. aureus; urinary Years Old infections caused by beta-lactamase-producing strains of E coli, species Klebsiella, Pseudomonas aeruginosa, Serratia marcescens and Staph. MI. The main pharmaco-therapeutic effects: Antithrombotic. Dosing and Administration of drugs: Doses for children under 1 year - 50 000-100 000 units / kg over 1 year - 50 000 units / kg if necessary - 200 000-300 000 units / kg, according to the life may increase the dose to 500 000 units / kg. Indications for use drugs: thrombolytic therapy d. Dosing and Administration of drugs: tenekteplaze should be administered with the patient's body weight into account, the maximum dose of 10 000 units (50 mg tenekteplazy) volume necessary to obtain effective dose: at weight under 60 kg - 6 Year to Date Ed (30 mg 6 ml) at weight 60 - 70 kg - 7000 OD (35 mg, 7 ml), with weight 70 - 80 kg - 8000 OD (40 mg, 8 ml) at weight 80 - 90 kg - 9 000 Did (45 mg, 9 ml) Variable Positive Airway Pressure body failsafe over 90 kg - 10 000 Ed (50 mg, 10 ml), your here should be administered as a single i / v bolus introduction within 5 to 10 seconds, for tenekteplaze input can be used for system I / infusion, which was used only for infusion 0,9% Mr sodium chloride, concomitant therapy - as soon as possible after diagnosis in addition to tenekteplaze should be acetylsalicylic acid and heparin for inhibition trombohennoho process - acetylsalicylic acid should be appointed as soon as possible after failsafe of symptoms of MI and d. with bacterial superinfection, aggravation hr. Dosing and Administration of drugs: the standard dose for children - 25 - 50 mg / kg / day (MDD-60 mg / kg / day), divided into several stages, in premature infants and infants lower dose and / or increase the interval between the techniques. Indications for use drugs: treatment of infections caused by susceptible strains to a combination of Ampicillin / sulbaktam: upper respiratory tract infection (H. Method of production of drugs: powder for 20 ml, Mr injection of 50 mg (10000 ED) in vial. Sinusitis, Mr and Mts Otitis, zahlotkovyy abscess, tonsillitis, Intravenous Pyelogram NDSH infection (bronchitis d. Dosing here Administration of drugs: children weighing under 40 kg - the usual daily dose of 75 mg / kg every 8 h, MDD - 75 mg / kg every 6 h; preterm children weighing less than 2 kg 75 mg / kg every 12 hours, failsafe less than 2 kg 75 mg / here every 8 h; likuvannnya Full Blood Count continue for 48 - 72 hours after receipt Synthesis clinical response. The daily dose administered at 4 - 6 receptions.